Nanopharm, LLC

LAWRENCE, KS 66047

SBIR Award Summary

Total Number of Awards 2
Total Value of Awards $598K
First Award Date 09/18/15
Most Recent Award Date 02/01/17

Key Personnel

Last Name Name Awards Contact
GROER CHAD GROER 2

2 Awards Won

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-15-269
Budget: 02/01/17 - 01/31/18

Significance- Lung cancer is the leading cause of cancer deaths with over 200,000 new diagnoses annually. Survival rate of lung cancer patients is correlated with the extent of lymph node metastasis. Standard care includes chemotherapy, radiation, and/or surgery. Cisplatin is a first-line chemotherapy for lung cancer, but systemic intravenous (I...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/18/15 - 06/17/16

Breast cancer is the second-leading cause of cancer deaths in women in the US. Despite initial treatment response, most patients progress to late-stage disease with metastases, likely due to resistant cancer stem cells (CSC) initiating tumor recurrence. CD44 and CD133 expression and increased ALDH1activity strongly correlate with breast cancer c...